Biblio

Export 34 results:
Author [ Title(Desc)] Type Year
Filters: Author is Scheltens, Philip  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
W. M. van der Flier and Scheltens, P., “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., “Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.”, J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
B. L. R. Reijs, Vos, S. J. B., Soininen, H., Lötjönen, J., Koikkalainen, J., Pikkarainen, M., Hall, A., Vanninen, R., Liu, Y., Herukka, S. - K., Freund-Levi, Y., Frisoni, G. B., Frölich, L., Nobili, F., Rikkert, M. Olde, Spiru, L., Tsolaki, M., Wallin, A. K., Scheltens, P., Verhey, F., and Visser, P. Jelle, “Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1387-1395, 2017.
C
J. J. Claus, Coenen, M., Staekenborg, S. S., Schuur, J., Tielkes, C. E. M., Koster, P., and Scheltens, P., “Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.”, J Alzheimers Dis, 2018.
O. N. Groeneveld, Moneti, C., Heinen, R., de Bresser, J., Kuijf, H. J., Exalto, L. G., Boomsma, J. M. F., L Kappelle, J., Barkhof, F., Prins, N. D., Scheltens, P., van der Flier, W. M., and Biessels, G. Jan, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., “Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
A. - M. Miller, Balasa, M., Blennow, K., Gardiner, M., Rutkowska, A., Scheltens, P., Teunissen, C. E., Visser, P. Jelle, Winblad, B., Waldemar, G., and Lawlor, B., “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
D
S. S. Staekenborg, Pijnenburg, Y. A. L., Lemstra, A. W., Scheltens, P., and Flier, W. M. Vd, “Dementia and Rapid Mortality: Who is at Risk?”, J Alzheimers Dis, vol. 53, no. 1, pp. 135-42, 2016.
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H., “The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
E. G. B. Vijverberg, Wattjes, M. P., Dols, A., Krudop, W. A., Möller, C., Peters, A., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., van Berckel, B. N. M., Barkhof, F., and Pijnenburg, Y. A. L., “Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1287-97, 2016.
W. J. Jansen, Handels, R. L. H., Visser, P. Jelle, Aalten, P., Bouwman, F., Claassen, J., van Domburg, P., Hoff, E., Hoogmoed, J., Leentjens, A. F. G., Rikkert, M. Olde, Oleksik, A. M., Smid, M., Scheltens, P., Wolfs, C., Verhey, F., and Ramakers, I. H. G. B., “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S., “Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
E
J. Cummings, Scheltens, P., McKeith, I., Blesa, R., Harrison, J. E., Bertolucci, P. H. F., Rockwood, K., Wilkinson, D., Wijker, W., Bennett, D. A., and Shah, R. C., “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
F
F. T. Gossink, Dols, A., Krudop, W. A., Sikkes, S. A., Kerssens, C. J., Prins, N. D., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “Formal Psychiatric Disorders are not Overrepresented in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1249-56, 2016.
G
M. Muurling, Rhodius-Meester, H. F. M., Pärkkä, J., van Gils, M., Frederiksen, K. S., Bruun, M., Hasselbalch, S. G., Soininen, H., Herukka, S. - K., Hallikainen, M., Teunissen, C. E., Visser, P. Jelle, Scheltens, P., van der Flier, W. M., Mattila, J., Lötjönen, J., and de Boer, C., “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
H
E. Louwersheimer, M Keulen, A., Steenwijk, M. D., Wattjes, M. P., Jiskoot, L. C., Vrenken, H., Teunissen, C. E., van Berckel, B. N. M., van der Flier, W. M., Scheltens, P., van Swieten, J. C., and Pijnenburg, Y. A. L., “Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 581-90, 2016.
I
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., “Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
L
A. Hafkemeijer, Möller, C., Dopper, E. G. P., Jiskoot, L. C., van den Berg-Huysmans, A. A., van Swieten, J. C., van der Flier, W. M., Vrenken, H., Pijnenburg, Y. A. L., Barkhof, F., Scheltens, P., van der Grond, J., and Rombouts, S. A. R. B., “A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 521-537, 2017.
J. J. Claus, Staekenborg, S. S., Roorda, J. J., Stevens, M., Herderschee, D., van Maarschalkerweerd, W., Schuurmans, L., Tielkes, C. E. M., Koster, P., Bavinck, C., and Scheltens, P., “Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting.”, J Alzheimers Dis, vol. 50, no. 3, pp. 797-806, 2016.
P
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
C. E. Teunissen, Chiu, M. - J., Yang, C. - C., Yang, S. - Y., Scheltens, P., Zetterberg, H., and Blennow, K., “Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1857-1863, 2018.
N. M. E. Scheltens, Tijms, B. M., Heymans, M. W., Rabinovici, G. D., Cohn-Sheehy, B. I., Miller, B. L., Kramer, J. H., Wolfsgruber, S., Wagner, M., Kornhuber, J., Peters, O., Scheltens, P., and van der Flier, W. M., “Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.”, J Alzheimers Dis, 2018.

Pages